IPSC
Century Therapeutics Inc.
$0.58
-$0.01(-1.50%)
49
Overall
60
Value
58
Tech
31
Quality
Market Cap
$53.54M
Volume
653.05K
52W Range
$0.34 - $1.83
Target Price
$4.40
Order:
Income Statement
| Metric | Trend | Chart | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
|---|---|---|---|---|---|---|
| REVENUE | ||||||
| Total Revenue | -- | $5.2M | $2.2M | $6.6M | ||
| Total Revenue | -- | $5.2M | $2.2M | $6.6M | ||
| GROSS PROFIT | ||||||
| Gross Profit | -- | $5.2M | $2.2M | $6.6M | ||
| OPERATING EXPENSES | ||||||
| Operating Expenses | $94.9M | $129.0M | $148.8M | $144.7M | ||
| Research & Development | $75.6M | $97.2M | $92.7M | $107.2M | ||
| Research Expense | $75.6M | $97.2M | $92.7M | $107.2M | ||
| Selling, General & Administrative | $19.2M | $31.9M | $34.7M | $33.2M | ||
| General & Administrative Expenses | $19.2M | $31.9M | $34.7M | $33.2M | ||
| Salaries & Wages | -- | -- | $14.6M | $12.7M | ||
| Depreciation & Amortization | $3.7M | $8.4M | $13.0M | $13.3M | ||
| Depreciation & Amortization | $3.7M | $8.4M | $13.0M | $13.3M | ||
| Amortization | $306.0K | $299.0K | $94.0K | -- | ||
| Other Operating Expenses | $5.6M | $8.7M | $8.1M | $9.4M | ||
| OPERATING INCOME | ||||||
| Operating income | $-94.9M | $-133.8M | $-146.5M | $-138.1M | ||
| EBITDA | $-90.5M | $-120.9M | $-121.1M | $-111.5M | ||
| NON-OPERATING ITEMS | ||||||
| Interest Expense (Non-Operating) | $1.3M | $1.2M | $540.0K | -- | ||
| Intinc | -- | -- | $12.7M | $13.0M | ||
| Net Non-Operating Interest Income/Expense | $-1.3M | $-3.0M | $12.7M | $13.0M | ||
| Other Income/Expense | $898.0K | $-10.0M | $383.0K | $-354.0K | ||
| Other Special Charges | $-898.0K | $3.0M | $-383.0K | $354.0K | ||
| SPECIAL ITEMS | ||||||
| Restructring And Mn A Income | -- | -- | -- | $-6.6M | ||
| Special Income Charges | -- | -- | $-16.4M | $-4.3M | ||
| Impairment of Capital Assets | -- | -- | $16.4M | $4.3M | ||
| PRE-TAX INCOME | ||||||
| EBIT | $-94.5M | $-129.6M | $-134.3M | $-124.8M | ||
| Pre-Tax Income | $-95.8M | $-130.8M | $-134.8M | $-124.8M | ||
| INCOME TAX | ||||||
| Tax Provision | $43.0K | $91.0K | $1.9M | $1.8M | ||
| NET INCOME | ||||||
| Net Income | $-95.8M | $-130.9M | $-136.7M | $-126.6M | ||
| Net Income (Continuing Operations) | $-95.8M | $-130.9M | $-136.7M | $-126.6M | ||
| Net Income (Discontinued Operations) | $-95.8M | $-130.9M | $-136.7M | $-126.6M | ||
| Net Income (Common Stockholders) | $-95.8M | $-120.9M | $-136.7M | $-126.6M | ||
| Normalized Income | $-75.7M | -- | -- | $-125.8M | ||
| TOTALS | ||||||
| Total Expenses | $94.9M | $129.0M | $148.8M | $144.7M | ||
| SHARE & EPS DATA | ||||||
| Average Shares Outstanding | $32.4M | $57.8M | $59.3M | $78.6M | ||
| Average Shares Outstanding (Diluted) | $32.4M | $57.8M | $57.8M | $78.6M | ||
| Shares Outstanding | $58.8M | $59.2M | $64.8M | $86.0M | ||
| Basic EPS | $-2.96 | $-2.27 | $-2.3 | $-1.61 | ||
| Basic EPS (Continuing Operations) | $-2.96 | $-2.27 | $-2.3 | $-1.61 | ||
| Diluted EPS | $-2.96 | $-2.27 | $-2.3 | $-1.61 | ||
| Diluted EPS (Continuing Operations) | $-2.96 | $-2.27 | $-2.27 | $-1.61 | ||
| OTHER METRICS | ||||||
| Other Gand A | $19.2M | $31.9M | $34.7M | $33.2M | ||
| Other Impairment Of Capital Assets | -- | -- | $11.4M | -- | ||
| Restruct | -- | -- | -- | $-6.6M | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | IPSC | $0.58 | -1.5% | 653.05K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Century Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW